Sanofi Consumer Healthcare India reports Q2 2025 PAT at Rs. 60.7 Cr
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
NewCo’s pipeline includes five investigational medicines
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Subscribe To Our Newsletter & Stay Updated